Abstract
Nowadays the determination of inhibitors of carbonic anhydrase isoenzymes (CAs) have become one of the main goals of drug design studies, and inhibitors of CAs have taken their place in clinical applications to be used in the treatment and diagnosis of many diseases from glaucoma to cancer. On the other hand, acetylcholinesterase (AChE) inhibitors are also the main target molecules for the treatment of Alzheimer’s disease. However, the unwanted side effects of existing CA and AChE inhibitors necessitate the identification of new and selective inhibitors of these enzymes. In this study, we examined the inhibition effects of some natural antiproliferative agents on CA-I, CA-II, and AChE activities isolated from human erythrocytes. Betulinic acid (I) had the strongest inhibitory effect on esterase activity of hCA-I (IC50 29.16 µM) and hCA-II (IC50 31.82 µM). On the other hand, sanguinarine chloride (VI) had the strongest inhibitory effect (IC50: 19.44 µM) on hAChE activity. Molecular modeling studies were also carried out to elucidate the inhibition mechanism of betulinic acid on hCA-I and hCA-II isoenzymes and sanguinarine chloride on the hAChE enzyme. We believe that the results we obtained in this study will contribute to the design of new and natural CA and AChE inhibitors.
Similar content being viewed by others
REFERENCES
Alım, Z., Kılınç, N., Şengül, B., and Beydemir, Ş., Chem. Biol. Drug Des., 2015, vol. 86, pp. 857–863. https://doi.org/10.1111/cbdd.12561
Alım, Z., J. Biochem. Mol. Toxicol., 2018, vol. 32, article ID e22194. https://doi.org/10.1002/jbt.22194
Köksal, Z., Alım, Z., Bayrak, S., Gülçin, I., and Özdemir, H., J. Biochem. Mol. Toxicol., 2019, vol. 33, article ID e22300. https://doi.org/10.1002/jbt.22300
Guney, M., Çavdar, H., Sentürk, M., and Ekinci, D., Bioorg. Med. Chem. Lett., 2015, vol. 25, pp. 3261–3263. https://doi.org/10.1016/j.bmcl.2015.05.073
Kumar, S., Rulhania, S., Jaswal, S., and Monga, V., Eur. J. Med. Chem., 2021, vol. 209, article ID 112923. https://doi.org/10.1016/j.ejmech.2020.112923
Jensen, E.L., Clement, R., Kosta, A., Maberly, S.C., and Gontero, B., Isme J., 2019, vol. 13, pp. 2094–2106. https://doi.org/10.1038/s41396-019-0426-8
Pretea, S.D., Nocentinib, A., Supuran, C.T., and Capassoa, C., J. Enzyme Inhib. Med. Chem., 2020, vol. 35, pp. 1060–1068. https://doi.org/10.1080/14756366.2020.1755852
Supuran, C.T., Expert Opin. Drug Discov., 2017, vol. 12, pp. 61–88. https://doi.org/10.1080/17460441.2017.1253677
Bhatt, A., Mahon, B.P., Cruzeiro, V.W.D., Cornelio, B., Laronze-Cochard, M., Ceruso, M., Sapi, J., Rance, G.A., Khlobystov, A.N., Fontana, A., Roitberg, A., Supuran, C.T., and McKenna, R., ChemBioChem, 2017, vol. 18, pp. 213–222. https://doi.org/10.1002/cbic.201600513
Alterio, V., Langella, E., Viparelli, F., Vullo, D., Ascione, G., Dathan, N.A., Morel, F.M.M., Supuran, C.T., Desimone, G., and Monte, S.M., Biochimie, 2012, vol. 94, pp. 1232–1241. https://doi.org/10.1016/j.biochi.2012.02.013
Kalaycı, M., Turkeş, C., Arslan, M., Demir, Y., and Beydemir, S., Arch. Pharm., 2020, vol. 354, article ID 2000282. https://doi.org/10.1002/ardp.202000282
Pinard, M.A., Mahon, B., and McKenna, R., Biomed. Res. Int., 2015, article ID 453543. https://doi.org/10.1155/2015/453543
Hekman, M.C.H., Rijpkema, M., Aarntzen, E.H., Mulder, S.F., Langenhuijsen, J.F., Oosterwijk, E., Boerman, O.C., Oyen, W.J.G., and Mulders, P.F.A., Eur. Urol., 2018, vol. 74, pp. 257–260. https://doi.org/10.1016/j.eururo.2018.04.026
Andreucci, E., Ruzzolini, J., Peppicelli, S., Bianchini, F., Laurenzana, A., Carta, F., Supuran C.T., and Calorini, L., J. Enzym Inhib. Med. Chem., 2019, vol. 34, pp. 117–123. https://doi.org/10.1080/14756366.2018.1532419
Alterio, V., Kellner, M., Esposito, D., Liesche-Starnecker, F., Bua, S., Supuran, C.T., Monti, S.M., Zeidler, R., and DeSimone, G., J. Mol. Biol., 2019, vol. 431, pp. 4910–4921. https://doi.org/10.1016/j.jmb.2019.10.022
Turkes, C., Arslan, M., Demir, Y., Çoçajd, D., Nixhad, A.R., and Beydemir, S., Bioorg. Chem., 2019, vol. 89, article ID 103004. https://doi.org/10.1016/j.bioorg.2019.103004
Alım, Z., Köksal, Z., and Karaman, M., Pharmacol. Rep., 2020, vol. 72, pp. 1738–1748. https://doi.org/10.1007/s43440-020-00149-4
Temperini, C., Innocenti, A., Scozzafava, A., Mastrolorenzo, A., and Supuran, C.T., Bioorg. Med. Chem. Lett., 2007, vol. 17, pp. 628–635. https://doi.org/10.1016/j.bmcl.2006.11.027
Supuran, C.T., Nat. Rev. Drug. Discov., 2008, vol. 7, pp. 168–181. https://doi.org/10.1038/nrd2467
Scozzafava, A., Mastrolorenzo, A., and Supuran, C.T., Expert Opin. Ther. Pat., 2004, vol. 14, pp. 667–702. https://doi.org/10.1517/13543776.14.5.667
Supuran, C.T., and Scozzafava, A., Bioorg. Med. Chem., 2007, vol. 15, pp. 4336–4350. https://doi.org/10.1016/j.bmc.2007.04.020
Sever, B., Türkeş, C., Altıntop, M.D., Demir, Y., and Beydemir, S., Int. J. Biol. Macromol., 2020, vol. 163, pp. 1970–1988. https://doi.org/10.1016/j.ijbiomac.2020.09.043
Aydın, B.O., Anıl, D., and Demir, Y., Arch. Pharm., 2021, vol. 354, article ID 2000330. https://doi.org/10.1002/ardp.202000330
Bilginer, S., Gul, H.I., Anil, B., and Demir, Y., Arch. Pharm., 2021, vol. 354, article ID 2000243. https://doi.org/10.1002/ardp.202000243
Kucukoglu, K., Gul, H.I., Taslimi, P., Gulcin, I., and Supuran, C.T., Bioorg. Chem., 2019, vol. 86, pp. 316–321. https://doi.org/10.1016/j.bioorg.2019.02.008
Adem, S., Akkemik, E., Aksit, H., Guller, P., Tüfekci, A.R., Demirtas, I., and Ciftci, M., Med. Chem. Res., 2019, vol. 28, pp. 711–722. https://doi.org/10.1007/s00044-019-02329-1
Güller, P., Dağalan, Z., Güller, U., Çalışır, U., and Nişancı, B., J. Mol. Struct., 2021, vol. 1239, p. 130498. https://doi.org/10.1016/j.molstruc.2021.130498
Zhang, X., Hu, J., and Chen, Y., Mol. Med. Rep., 2016, vol. 14, pp. 4489–4495. https://doi.org/10.3892/mmr.2016.5792
Vanchanagiri, K., Emmerich, D., Bruschke, M., Bache, M., Seifert, F., Csuk, R., Vordermark, D., and Paschke, R., Chem. Biol. Interact., 2018, vol. 25, pp. 12–23. https://doi.org/10.1016/j.cbi.2018.02.014
Karioti, A., Ceruso, M., Carta, F., Bilia, A.R., and Supuran, C.T., Bioorg. Med. Chem., 2015, vol. 23, pp. 7219–7225. https://doi.org/10.1016/j.bmc.2015.10.018
Butini S., Campiani G., Borriello M., Gemma S., Panico A., Persico M., Catalanotti, B., Ros, S., Brindisi, M., Agnusdei, M., Fiorini, I., Nacci, V., Novellino, E., Belinskaya, T., Saxena, A., and Fattorusso, C., J. Med. Chem., 2008, vol. 51, pp. 3154–3170. https://doi.org/10.1021/jm701253t
Shi, J., Boyd, A.E., Radic, Z., and Taylor, P., J. Biol. Chem., 2001, vol. 276, pp. 42196–42204. https://doi.org/10.1074/jbc.M106896200
Bradford, M.M., Anal. Biochem., 1976, vol. 72, pp. 248–254. https://doi.org/10.1016/0003-2697(76)90527-3
Laemmli, U.K., Nature, 1970, vol. 227, pp. 680–685. https://doi.org/10.1038/227680a0
Guller, U., Guller, P., and Çiftçi, M., Altern. Ther. Health. Med., 2020, article ID 32619207.
Verpoorte, J.A., Mehta, S., and Edsall, J.T., J. Biol. Chem., 1967, vol. 242, pp. 4221–4229. https://doi.org/10.1016/S0021-9258(18)95800-X
Ellman, G.L., Courtney, K.D., Andres Jr, V., and Featherstone, R.M., Biochem. Pharmacol., 1961, vol. 7, pp. 88–95. https://doi.org/10.1016/0006-2952(61)90145-9
Worek, F., Mast, U., Kiderlen, D., Diepold, C., and Eyer, P., Clin. Chim. Acta, 1999, vol. 288, pp. 73–90. https://doi.org/10.1016/S0009-8981(99)00144-8
Gök, N., Akıncıoğlu, A., Binici, E.E., Akıncıoğlu, H., Kılınç, N., and Göksu, S., Arch. Pharm., 2021, vol. 354, article ID e2000496. https://doi.org/10.1002/ardp.202000496
Schrödinger Release 2020-3, Maestro, Schrödinger, LLC, New York, NY, 2020.
Sastry, G.M., Adzhigirey, M., Day, T., Annabhimoju, R., and Sherman, W., J. Comput. Aid. Mol. Des., 2013, vol. 27, pp. 221–234. https://doi.org/10.1007/s10822-013-9644-8
Sherman, W., Day, T., Jacobson, M.P., Friesner, R.A., and Farid, R., J. Med. Chem., 2006, vol. 49, pp. 534–553. https://doi.org/10.1021/jm050540c
Sandor, M., Kiss, R., and Keseru, G.M., J. Chem. Inf. Model., 2010, vol. 50, pp. 1165–1172. https://doi.org/10.1021/ci1000407
Genheden, S. and Ryde, U., Expert Opin. Drug Discov., 2015, vol. 10, pp. 449–461. https://doi.org/10.1517/17460441.2015.1032936
Prime, Schrödinger, LLC, New York, NY, 2020.
QikProp, Schrödinger, LLC, New York, NY, 2020.
Funding
The authors thank to Igdir University Research Fund Accounting for their support to carry out this work (project no. 2020-SBE-A03).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
Healthy human erythrocytes used in this study were obtained from Atatürk University blood center. Other than that, it does not include any studies involving human participants by any of the authors, and does not include any animal studies performed by any author.
Conflict of Interests
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Kılınç, N., Güller, U. & Alım, Z. Identification of the Inhibition Effects of Some Natural Antiproliferative Agents on CA-I, CA-II, and AChE Activities Isolated from Human Erythrocytes by Kinetic and Molecular Docking Studies. Russ J Bioorg Chem 48, 720–730 (2022). https://doi.org/10.1134/S1068162022040124
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162022040124